Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial. - Wikidata - wikimedia - TriplyDB

Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial.

Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial.

http://www.wikidata.org/entity/Q37277979

about

Glycaemic, blood pressure and cholesterol control in 25 629 diabetics Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.Quality of Care for Patients with Type 2 Diabetes Mellitus in Dubai: A HEDIS-Like Assessment.Benchmarking Controlled Trial--a novel concept covering all observational effectiveness studies Patient-centeredness and quality management in Dutch diabetes care organizations after a 1-year intervention.Feedback GAP: pragmatic, cluster-randomized trial of goal setting and action plans to increase the effectiveness of audit and feedback interventions in primary care.Effects of benchmarking on the quality of type 2 diabetes care: results of the OPTIMISE (Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment) study in Greece.Diabetes quality of care at a university community in Beirut.Benchmarking by HbA1c in a national diabetes quality register--does measurement bias matter?Interventions to increase attendance for diabetic retinopathy screening.Developing a set of indicators to monitor quality in ambulatory diabetes care using a modified Delphi panel process.Risk-adjustment of diabetes health outcomes improves the accuracy of performance benchmarking.

P2860

Q26781082-778690D8-89B2-4F34-8367-DA0BF5ECA107 Q35689882-F58ECF9D-2D87-4E2B-A784-A4082A5780F0 Q35690776-25559944-15AF-4D10-94DB-A26F61F01F17 Q36357077-BECF716B-EC51-4AAA-971F-90FD19EDC2F5 Q37337623-E8D5330C-6E23-4A3F-8F0B-7A0BEB1C31C5 Q37426659-1EA81D06-2B7E-4FDA-B655-12F340796669 Q38402322-6ACD260C-751B-48C2-93E3-A73064151825 Q40924177-588308A2-9C1D-4A7C-90DD-FC91B3222AF5 Q41695247-97126BA2-E834-4CC6-9538-61EF3C31A426 Q47559649-974E8E52-B5E8-4E89-99BB-C4200B240451 Q50014683-4694D1A3-3107-4343-B281-8F23D06D9FF9 Q55644984-068BA0CC-E05E-4130-ADD9-DB8397B64F4B

P2860

Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial.

http://www.wikidata.org/entity/Q37277979

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Benchmarking is associated wit ...... randomized, controlled trial.

@en

Benchmarking is associated wit ...... randomized, controlled trial.

@nl

type

label

Benchmarking is associated wit ...... randomized, controlled trial.

@en

Benchmarking is associated wit ...... randomized, controlled trial.

@nl

prefLabel

Benchmarking is associated wit ...... randomized, controlled trial.

@en

Benchmarking is associated wit ...... randomized, controlled trial.

@nl

P1433

Q37277979-0ECB9366-B53B-43D9-B4A8-CCD058F05E29

P1476

Q37277979-8DE3EEE3-EC23-4402-90B2-D8B9634B06CD

P2093

Q37277979-1BFDFB37-CF0B-47B8-BF4A-054254338F87

Q37277979-1DCE3174-B8A1-41E8-8E16-E54293ABDB55

Q37277979-59045FE1-60F9-4113-B386-FAA0A6C0BF49

Q37277979-5F90F4AE-A6BB-4053-9E79-E966486F538B

Q37277979-66213743-4384-4605-92C8-72BAD47F767F

Q37277979-9B039EF1-ABF3-4646-A3AE-A5AFBF14262B

Q37277979-A1BD9326-7593-413C-87C2-8A228B7BE026

P2860

Q37277979-1FB19359-4252-40C4-94C0-7B6A94E75DE5

Q37277979-25E9B809-9D0B-4BAC-BA8B-78D56300D892

Q37277979-323C2CA3-F776-4F02-A001-F5AC52F4700F

Q37277979-36507A58-9F6B-4FC3-9FA0-D782754B6D78

Q37277979-3830F76D-A80D-4586-A1C5-28F17399EE88

Q37277979-39AC0305-FA1C-41DD-9073-74001221EAAF

Q37277979-6065A6D9-78B4-4284-93CB-8F4A499CFD93

Q37277979-66CB96A2-89B7-48A5-A90D-807CBFA26C6C

Q37277979-6A853597-51BF-4497-8602-2363D50F9C05

Q37277979-6B7B735A-5CBC-4FBB-95B2-A4E0F7561A72

P304

Q37277979-783BB1BC-0BCE-42E7-9AF0-385C74921217

P31

Q37277979-E71B6803-A038-4C12-ADD3-8D406F3B2D76

P356

Q37277979-A0ACAA94-E21E-40DE-A760-E4218F794AD0

P407

Q37277979-39A505C7-07E7-4219-9907-7AA2AE22E028

P433

Q37277979-CEED9A53-B1DF-4B75-8A95-CA6B929A6DB7

P478

Q37277979-C3B6FDAC-F5C0-4C73-B3F1-EB403A020EFB

P50

Q37277979-D5568DC4-7B3E-4A0C-A23F-CB0036136F63

P577

Q37277979-47ECE1A4-9CEC-42AC-9ABB-D7FAEF336942

P5875

Q37277979-172BC5AB-EA0B-473A-BD73-4ACB5CD0FE3E

P698

Q37277979-E084EBEF-19DF-4E0B-AABC-8E2297B20579

P921

Q37277979-2019739D-95CD-4242-A7AB-32DBDF3B4806

P932

Q37277979-C989DE19-C479-4242-AA3F-F9839E4D9DA4

P356

P1433

P1476

Benchmarking is associated wit ...... randomized, controlled trial.

@en

P2093

Carlos Brotons

http://www.w3.org/2001/XMLSchema#string

Erik Muls

http://www.w3.org/2001/XMLSchema#string

Frank Nobels

http://www.w3.org/2001/XMLSchema#string

Georges Michel

http://www.w3.org/2001/XMLSchema#string

Hans Vandenberghe

http://www.w3.org/2001/XMLSchema#string

Michel P Hermans

http://www.w3.org/2001/XMLSchema#string

OPTIMISE International Steering Committee

http://www.w3.org/2001/XMLSchema#string

P2860

The Hawthorne Effect: a randomised, controlled trial

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Is untargeted educational outreach visiting delivered by pharmaceutical advisers effective in primary care? A pragmatic randomized controlled trial.

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Attainment of Canadian Diabetes Association recommended targets in patients with type 2 diabetes: a study of primary care practices in St John's, Nfld.

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Meta-analysis: audit and feedback features impact effectiveness on care quality.

P304

3388-3395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC12-1853

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262043805

http://www.w3.org/2001/XMLSchema#string

P698

23846810

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3816864

http://www.w3.org/2001/XMLSchema#string